The distinction must be made between the elevation of EtCO2 as a result of sodium bicarbonate administration and elevation of CO2 from non-optimal ventilation. The former is a consequence of alkalinization and will be associated with a concomitant increase in pH and lowered pulmonary artery pressures. The later is obviously the opposite.
To think that the increase in EtCO2 seen with bicarb. administration makes it an undesirable drug in the setting of pulmonary hypertension is exactly incorrect because the actual PaCO2 does not necessarily increase and pH certainly does...assuming ventilation is maintained.
Pulmonary vascular resistance in infants after cardiac surgery: role of carbon dioxide and hydrogen ion. - PubMed - NCBI
The other week I found myself helping with a coding chronic lung disease infant in the PICU with known suprasystemic pulmonary hypertension. He had been given 3 rounds of epinephrine and when I showed up, I asked if any bicarbonate had been given. The looks I got made me realize they thought it an 'out there', 'outdated, 'not in the PALS algorithm' idea. 4mEq/kg bolus resulted in almost immediate return of heart rate, oxygenation and blood pressure. I haven't been in practice that long but I have dealt with my fair share of pulmonary hypertension in the peds cath lab and the cardiac ORs and it works well for rescue or even pushing patients back from the ledge.